MAPK3 and gastric cancer: ERK1/2 mediates NF-κB activation through a mechanism involving MAPK/p90RSK/IκBα signaling [38]; similarly, we demonstrated that this pathway was required for ILK-mediated NF-κB activation in gastric cancer cells.